HDAC3 and neoplasm: Ashwini et al. provided molecular evidence that butyrate inhibits glioblastoma cell proliferation through histone deacetylase-3 (HDAC3) inhibition, suggesting epigenetic mechanisms underlying microbiome-mediated tumor suppression [27].